Shandong Boan Biotechnology Co (FRA:UJ9) Shares Outstanding (EOP): 622.33 Mil (As of Dec. 2025)


FRA:UJ9 Shandong Boan Biotechnology Co Ltd FRA:UJ9
39 GF Score
Price €0.52
GF Value €1.70
! 5 Warning Signs
View Full Analysis

What is Shandong Boan Biotechnology Co Shares Outstanding (EOP)?

Shandong Boan Biotechnology Co FRA:UJ9 -3.70% 39 Shares Outstanding (EOP) is 622.33 Mil as of Dec. 2025. GuruFocus rates FRA:UJ9 with a GF Score™ of 39/100 and a GF Value™ of €1.70. The stock has 5 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Shandong Boan Biotechnology Co's shares outstanding for the quarter that ended in Dec. 2025 was 622.33 Mil.

Shandong Boan Biotechnology Co's quarterly shares outstanding increased from Jun. 2025 (574.33 Mil) to Dec. 2025 (622.33 Mil). It means Shandong Boan Biotechnology Co issued new shares from Jun. 2025 to Dec. 2025 .

Shandong Boan Biotechnology Co's annual shares outstanding increased from Dec. 2024 (535.93 Mil) to Dec. 2025 (622.33 Mil). It means Shandong Boan Biotechnology Co issued new shares from Dec. 2024 to Dec. 2025 .


Shandong Boan Biotechnology Co  (FRA:UJ9) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Shandong Boan Biotechnology Co Shares Outstanding (EOP) Related Terms


Shandong Boan Biotechnology Co Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Shandong Boan Biotechnology Co's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Boan Biotechnology Co Shares Outstanding (EOP) Chart

Shandong Boan Biotechnology Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial 509.28 509.28 509.28 535.93 622.33

Shandong Boan Biotechnology Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 509.28 535.93 535.93 574.33 622.33

FRA:UJ9 vs VRTX, REGN, ALNY: Shares Outstanding (EOP) Comparison

For the Biotechnology subindustry, Shandong Boan Biotechnology Co's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Boan Biotechnology Co Shares Outstanding (EOP) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shandong Boan Biotechnology Co's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Shandong Boan Biotechnology Co's Shares Outstanding (EOP) falls into.


FRA:UJ9
39GF Score
Shandong Boan Biotechnology Co Ltd FRA:UJ9
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Boan Biotechnology Co Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 622.33 Mil mean?
Shandong Boan Biotechnology Co (FRA:UJ9) has a Shares Outstanding (EOP) of 622.33 Mil as of Dec. 2025. The total shares a company has outstanding, at period-end. View historical data on Shandong Boan Biotechnology Co and its competitors.
Is Shandong Boan Biotechnology Co's Shares Outstanding (EOP) too high?
Shandong Boan Biotechnology Co's current Shares Outstanding (EOP) is 622.33 Mil. Overall, Shandong Boan Biotechnology Co has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Shandong Boan Biotechnology Co's Shares Outstanding (EOP) compare to VRTX and REGN?
Shandong Boan Biotechnology Co's Shares Outstanding (EOP) of 622.33 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Biotechnology company?
A good Shares Outstanding (EOP) depends on the Biotechnology industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Shandong Boan Biotechnology Co and its competitors. Shandong Boan Biotechnology Co's current Shares Outstanding (EOP) is 622.33 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Boan Biotechnology Co stock overvalued right now?
Shandong Boan Biotechnology Co (FRA:UJ9) has a current Shares Outstanding (EOP) of 622.33 Mil. The stock's GF Value™ is €1.70, compared to a current price of €0.52 — trading 69.4% below its estimated fair value. The current Shares Outstanding (EOP) is 622.33 Mil. Shandong Boan Biotechnology Co's overall GF Score™ is 39/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Shandong Boan Biotechnology Co (FRA:UJ9), the current Shares Outstanding (EOP) is 622.33 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shandong Boan Biotechnology Co (FRA:UJ9) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Boan Biotechnology Co stock appears to be undervalued. The current stock price of €0.52 is trading 69.4% below its estimated GF Value™ of €1.70.

Key valuation signals for FRA:UJ9:

  • Shares Outstanding (EOP): 622.33 Mil
  • GF Value™: €1.70 vs. price of €0.52 (69.4% below fair value)
  • GF Score™: 39/100 with 5 warning signs

No single metric tells the full story. See the FRA:UJ9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shandong Boan Biotechnology Co Business Description

Other Exchanges 06955:Hong Kong
Address No. 39 Keji Avenue, High-Tech Industrial Development Zone, Shandong Province, Yantai, CHN
Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. It is focused on developing, manufacturing, and marketing biologics, with a focus on oncology, autoimmune diseases, ophthalmology, and metabolic diseases. The company's drug discovery activities revolve around multiple platforms: Fully Human Antibody Platform, bsAb/msAb/Probody Platform, and ADC Platform. It has commercialized several products, such as Boyounuo, Boyoubei (denosumab injection 60 mg), Boluojia (denosumab injection 120 mg), Boyouping (dulaglutide injection), and Boyoujing; and is actively engaged in the development of other drugs like BA1104 (nivolumab injection), BA1106, BA1302 (an anti-CD228 ADC), etc. Geographically, the company generates maximum revenue from the Chinese mainland.
39GF Score

Get the complete analysis for FRA:UJ9

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.52
Price
€1.70
GF Value